• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response.

作者信息

Liou Harris, Mody Kabir, Boyle Ashton W, Keaveny Andrew P, Croome Kristopher P, Burns Justin M, Harnois Denise M, Patel Tushar C, Toskich Beau

机构信息

Alix School of Medicine, Mayo Clinic, Scottsdale, AZ.

Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.

出版信息

Hepatology. 2021 Jul;74(1):525-527. doi: 10.1002/hep.31675. Epub 2021 Apr 27.

DOI:10.1002/hep.31675
PMID:33615518
Abstract
摘要

相似文献

1
Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response.新辅助放疗、肺叶切除术及免疫疗法治疗血管浸润性肝癌并获得完全病理缓解
Hepatology. 2021 Jul;74(1):525-527. doi: 10.1002/hep.31675. Epub 2021 Apr 27.
2
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.肝细胞癌的新辅助和辅助治疗策略。
World J Gastroenterol. 2019 Jul 28;25(28):3704-3721. doi: 10.3748/wjg.v25.i28.3704.
3
Combining systemic and local therapies for hepatocellular carcinoma.肝细胞癌的全身治疗与局部治疗联合应用
Lancet Gastroenterol Hepatol. 2021 Dec;6(12):976-978. doi: 10.1016/S2468-1253(21)00388-5. Epub 2021 Oct 23.
4
Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.临床三角学：肝细胞癌放疗后右肝三段切除术。
Dig Dis Sci. 2018 Jun;63(6):1419-1423. doi: 10.1007/s10620-017-4797-2. Epub 2017 Nov 8.
5
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.钇 90 树脂微球放射性栓塞联合纳武利尤单抗治疗晚期肝细胞癌（CA 209-678）：一项单臂、单中心、2 期临床试验。
Lancet Gastroenterol Hepatol. 2021 Dec;6(12):1025-1035. doi: 10.1016/S2468-1253(21)00305-8. Epub 2021 Oct 23.
6
Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better?辅助和新辅助治疗在肝癌中为何失败。新的免疫疗法有望表现得更好吗？
J Gastrointest Cancer. 2020 Dec;51(4):1193-1196. doi: 10.1007/s12029-020-00497-7.
7
Successful management of the hepatocellular carcinoma with inferior vena cava tumor thrombus: A case report.成功治疗下腔静脉肿瘤栓子相关肝细胞癌：一例报告。
Medicine (Baltimore). 2021 May 28;100(21):e26081. doi: 10.1097/MD.0000000000026081.
8
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.放射叶切除术：不可切除肝癌作为切除桥接的未来剩余肝脏体积的时间依赖性分析。
J Hepatol. 2013 Nov;59(5):1029-36. doi: 10.1016/j.jhep.2013.06.015. Epub 2013 Jun 25.
9
Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma.钇-90 联合免疫检查点抑制剂免疫治疗肝癌的安全性。
J Vasc Interv Radiol. 2020 Jan;31(1):25-34. doi: 10.1016/j.jvir.2019.05.023. Epub 2019 Aug 14.
10
Preoperative immunotherapy for resectable hepatocellular carcinoma: Toward a paradigm shift?可切除肝细胞癌的术前免疫治疗：迈向范式转变？
J Hepatol. 2020 Dec;73(6):1588-1590. doi: 10.1016/j.jhep.2020.05.048. Epub 2020 Sep 17.

引用本文的文献

1
Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma.用于肝细胞癌的新辅助免疫检查点抑制剂
NPJ Precis Oncol. 2025 Mar 6;9(1):60. doi: 10.1038/s41698-025-00846-4.
2
Advancing microvascular invasion diagnosis: a multi-center investigation of novel MRI-based models for precise detection and classification in early-stage small hepatocellular carcinoma (≤ 3 cm).推进微血管侵犯诊断：一项基于新型MRI模型对早期小肝癌（≤3厘米）进行精确检测和分类的多中心研究。
Abdom Radiol (NY). 2025 May;50(5):1986-1999. doi: 10.1007/s00261-024-04463-w. Epub 2024 Sep 28.
3
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.
移植前免疫检查点抑制剂的使用对肝癌移植后结局的影响：一项系统评价和个体患者数据荟萃分析。
J Hepatol. 2025 Jan;82(1):107-119. doi: 10.1016/j.jhep.2024.06.042. Epub 2024 Jul 10.
4
Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma.经导管动脉化疗栓塞术（TACE）联合靶向免疫治疗中晚期肝细胞癌的安全性和有效性分析。
Med Oncol. 2023 Jul 27;40(9):251. doi: 10.1007/s12032-023-02082-x.
5
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies.肝脏定向治疗的潜在免疫治疗靶点，以及肝脏相关恶性肿瘤免疫治疗的当前范围。
Cancers (Basel). 2023 May 5;15(9):2624. doi: 10.3390/cancers15092624.
6
Imaging evaluation following transarterial radioembolization with yttrium-90 microspheres downstaging hepatocellular carcinoma: the first case in China.经动脉注射钇-90微球肝动脉放射性栓塞术使肝细胞癌降期后的影像学评估：中国首例报道
Quant Imaging Med Surg. 2023 Apr 1;13(4):2744-2750. doi: 10.21037/qims-22-943. Epub 2023 Feb 9.
7
Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.可切除肝细胞癌的新辅助免疫检查点抑制剂：系统评价与荟萃分析
Cancers (Basel). 2023 Jan 18;15(3):600. doi: 10.3390/cancers15030600.
8
Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy.吲哚菁绿荧光实时成像技术在腹腔镜肝切除术中的应用效果
Front Oncol. 2022 Apr 6;12:819960. doi: 10.3389/fonc.2022.819960. eCollection 2022.
9
Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice.放射性栓塞治疗肝细胞癌：走向个性化剂量测定与消融实践之路
Semin Intervent Radiol. 2021 Oct;38(4):466-471. doi: 10.1055/s-0041-1735571. Epub 2021 Oct 7.
10
Radiation Lobectomy: An Overview of Concept and Applications, Technical Considerations, Outcomes.放射叶切除术：概念与应用概述、技术考量及结果
Semin Intervent Radiol. 2021 Oct;38(4):419-424. doi: 10.1055/s-0041-1735530. Epub 2021 Oct 7.